Comparison of a polyethylene glycol membrane and a collagen membrane for the treatment of bone dehiscence defects at bone level implants—A prospective, randomized, controlled, multicenter clinical trial
Open Access
- 2 September 2020
- journal article
- research article
- Published by Wiley in Clinical Oral Implants Research
- Vol. 31 (11) , 1105-1115
Abstract
Objectives: The aim of the present randomized, controlled clinical multicenter trial was to compare a polyethylene glycol (PEG) and a native collagen membrane (BG) for simultaneous guided bone regeneration at bony dehiscence‐type defects around bone level titanium implants.Material and methods: The study enrolled 117 patients requiring implant treatment in the posterior maxilla or mandible with expected buccal bony dehiscence‐type defects at the placed titanium implants. According to a parallel groups design, defects were filled with a synthetic bone filler and randomly assigned to either PEG or BG membrane. As primary parameter, the relative vertical bone fill was assessed at baseline and at re‐entry after 6 months of healing. As secondary parameters, the marginal bone level (MBL) was assessed radiographically and soft tissue conditions were recorded up to 18 months postloading.Results: Both groups showed comparable vertical bone fill revealing a relative change in defect height of 59.7% (PEG) and 64.4% (BG). The absolute mean reduction in defect size was 2.5 mm in the PEG group and 3.2 mm in the BG group. Although both groups revealed a statistically significant mean defect reduction (p < .001), a comparison between the two groups did not show statistical significances. The non‐inferiority test with inferiority limit of −5% could not be rejected, based on the 90% confidence interval of the differences of the two means with lower limit −15.4%. After 18 months, an MBL increase of 0.45 ± 0.43 mm in the PEG group and 0.41 ± 0.81 mm in the BG group was detected (p < .001). Soft tissue complications were observed in both groups without showing statistical significance.Conclusions: Both membranes supported bone regeneration at dehiscence‐type defects and obtained vertical bone fill with a relative change in defect height of 59.7% (PEG) and 64.4% (BG); however, the non‐inferiority of PEG could not be shown.Keywords
This publication has 18 references indexed in Scilit:
- Long‐term outcome of implants placed with guided bone regeneration (GBR) using resorbable and non‐resorbable membranes after 12–14 yearsClinical Oral Implants Research, 2012
- Impact of the outcome of guided bone regeneration in dehiscence‐type defects on the long‐term stability of peri‐implant health: clinical observations at 4 yearsClinical Oral Implants Research, 2011
- Use of a new cross‐linked collagen membrane for the treatment of dehiscence‐type defects at titanium implants: a prospective, randomized‐controlled double‐blinded clinical multicenter studyClinical Oral Implants Research, 2009
- Clinical and radiographic comparison of implants in regenerated or native bone: 5‐year resultsClinical Oral Implants Research, 2009
- Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD‐peptide modifications: an immunohistochemical study in ratsClinical Oral Implants Research, 2009
- A randomized, controlled clinical trial to evaluate a new membrane for guided bone regeneration around dental implantsClinical Oral Implants Research, 2009
- Angiogenesis pattern of native and cross‐linked collagen membranes: an immunohistochemical study in the ratClinical Oral Implants Research, 2006
- Evaluation of an in situ formed synthetic hydrogel as a biodegradable membrane for guided bone regenerationClinical Oral Implants Research, 2006
- Biodegradation of differently cross‐linked collagen membranes: an experimental study in the ratClinical Oral Implants Research, 2005
- Healing of dehiscence‐type defects in implants placed together with different barrier membranes: a comparative clinical studyClinical Oral Implants Research, 2004